Kidney Transplantation Clinical Trials

52 recruitingLast updated: June 18, 2026

There are 52 actively recruiting kidney transplantation clinical trials across 20 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 4, Phase 3, Early Phase 1. Top locations include Montreal, Quebec, Canada, New York, New York, United States, Houston, Texas, United States. Updated daily from ClinicalTrials.gov.


Kidney Transplantation Trials at a Glance

52 actively recruiting trials for kidney transplantation are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Not Applicable with 18 trials, with the heaviest enrollment activity in Montreal, New York, and Houston. Lead sponsors running kidney transplantation studies include Nantes University Hospital, Assistance Publique - Hôpitaux de Paris, and United Therapeutics.

Browse kidney transplantation trials by phase

Treatments under study

About Kidney Transplantation Clinical Trials

Looking for clinical trials for Kidney Transplantation? There are currently 38 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Kidney Transplantation trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Kidney Transplantation clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 52 trials

Recruiting

The Mycophenolate Pregnancy Registry

Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases
Genentech, Inc.500 enrolled1 locationNCT01733082
Recruiting
Phase 2

Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients

HypophosphatemiaKidney Transplantation
Stanford University90 enrolled1 locationNCT06824454
Recruiting
Early Phase 1

Tolerance Through Mixed Chimerism (Sip-Tego)

Kidney FailureTransplant Recipient (Kidney)Immunosuppresion+2 more
Tatsuo Kawai, MD, PhD12 enrolled1 locationNCT06972069
Recruiting
Phase 1Phase 2

Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)

Kidney TransplantationKidney Failure, ChronicAlloimmunization+3 more
Hospital Universitari Vall d'Hebron Research Institute10 enrolled1 locationNCT07607197
Recruiting
Phase 1Phase 2

Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD

Kidney TransplantationXenotransplantationESRD (End-Stage Renal Disease)
United Therapeutics50 enrolled1 locationNCT07224763
Recruiting
Not Applicable

TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation

CancerInfectionKidney Transplantation+1 more
Hospices Civils de Lyon600 enrolled4 locationsNCT06829719
Recruiting
Not Applicable

Kidney Transplant Improvement Through New Exercise Training to Increase Capacity

Kidney FailureKidney TransplantationRenal Insufficiency, Chronic+7 more
University of Pennsylvania60 enrolled1 locationNCT07446296
Recruiting
Not Applicable

Testing the Feasibility of a Self-Management Support Program for Patient With Chronic Diseases in Israel

Cancer SurvivorshipChronic DiseaseKidney Transplantation
University of Haifa45 enrolled1 locationNCT07367750
Recruiting
Phase 1

Eight-Treg Study:Trial of Adoptive Immunotherapy With Autologous ex Vivo Expanded Regulatory CD8+ T Cells in Living Donor Kidney Transplant Recipients

Kidney Transplantation
Nantes University Hospital9 enrolled1 locationNCT06777719
Recruiting
Phase 2

Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation

Kidney TransplantationAMRAntibody-mediated Rejection+1 more
Alexion Pharmaceuticals, Inc.45 enrolled55 locationsNCT06744647
Recruiting
Phase 2

REgulatory T Cell Therapy to Achieve Immunosuppression REduction

Kidney Transplantation
Singulera Therapeutics Inc.34 enrolled7 locationsNCT06552169
Recruiting
Phase 2

Imlifidase Prior to Kidney Transplant in Highly Sensitised Children

Kidney Transplantation in Highly Sensitized Patients
Hansa Biopharma AB10 enrolled5 locationsNCT05753930
Recruiting
Not Applicable

Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage

Chronic Kidney Disease (Stages 4 and 5)Kidney Transplantation RecipientsEnd Stage Chronic Renal Failure
Vanderbilt University Medical Center30 enrolled1 locationNCT07385651
Recruiting
Phase 3

Shingrix in Renal Transplant Recipients

Kidney FailureKidney TransplantationKidney Failure, Chronic+2 more
University of Colorado, Denver132 enrolled4 locationsNCT04128189
Recruiting
Phase 1Phase 2

Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD

Kidney TransplantationXenotransplantationESRD (End-Stage Renal Disease)
United Therapeutics50 enrolled2 locationsNCT06878560
Recruiting
Phase 4

Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.

Kidney TransplantationMycophenolate Mofetil
Mayo Clinic350 enrolled3 locationsNCT06568549
Recruiting

Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity

Antibody Mediated Rejection After Kidney Transplantation
Assistance Publique - Hôpitaux de Paris45 enrolled2 locationsNCT07134491
Recruiting
Not Applicable

Impact of ExtraCorporeal Phototherapy (ECP) on Auxiliary Follicular T-lymphocytes and Circulating B-lymphocytes During Chronic AntiBody-Mediated Rejection in Kidney Transplantation.

Kidney Transplantation
University Hospital, Angers30 enrolled4 locationsNCT04870437
Recruiting
Not Applicable

Parathyroidectomy After Kidney Transplantation

HyperparathyroidismKidney Transplantation Recipients
Aarhus University Hospital85 enrolled1 locationNCT07415421
Recruiting
Phase 4

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

Liver Transplant; ComplicationsKidney Transplant; ComplicationsCytomegalovirus+2 more
Camille N. Kotton, MD80 enrolled2 locationsNCT06958796